GB0716591D0 - Composition - Google Patents

Composition

Info

Publication number
GB0716591D0
GB0716591D0 GB0716591A GB0716591A GB0716591D0 GB 0716591 D0 GB0716591 D0 GB 0716591D0 GB 0716591 A GB0716591 A GB 0716591A GB 0716591 A GB0716591 A GB 0716591A GB 0716591 D0 GB0716591 D0 GB 0716591D0
Authority
GB
United Kingdom
Prior art keywords
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0716591A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VERENIGING HET NEDERLANDS KANKER INSTITUUT
SLOTERVAART PARTICIPATIES BV
Original Assignee
VERENIGING HET NEDERLANDS KANKER INSTITUUT
SLOTERVAART PARTICIPATIES BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VERENIGING HET NEDERLANDS KANKER INSTITUUT, SLOTERVAART PARTICIPATIES BV filed Critical VERENIGING HET NEDERLANDS KANKER INSTITUUT
Priority to GB0716591A priority Critical patent/GB0716591D0/en
Publication of GB0716591D0 publication Critical patent/GB0716591D0/en
Priority to CN2008801042752A priority patent/CN101854919B/zh
Priority to CA2696622A priority patent/CA2696622C/en
Priority to EP08788414.4A priority patent/EP2190413B1/en
Priority to KR1020107004111A priority patent/KR101544498B1/ko
Priority to RU2010110658/15A priority patent/RU2488384C2/ru
Priority to PCT/GB2008/002854 priority patent/WO2009027644A2/en
Priority to MX2010002179A priority patent/MX2010002179A/es
Priority to BRPI0816144-5A priority patent/BRPI0816144B1/pt
Priority to HK10110968.5A priority patent/HK1144390B/en
Priority to ES08788414.4T priority patent/ES2535401T3/es
Priority to JP2010521478A priority patent/JP5404625B2/ja
Priority to AU2008291930A priority patent/AU2008291930B2/en
Priority to CL2009001766A priority patent/CL2009001766A1/es
Priority to US13/060,037 priority patent/US20110207804A1/en
Priority to ARP090103252A priority patent/AR073123A1/es
Priority to ZA2010/01304A priority patent/ZA201001304B/en
Priority to IL204115A priority patent/IL204115B/en
Ceased legal-status Critical Current

Links

GB0716591A 2007-08-24 2007-08-24 Composition Ceased GB0716591D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GB0716591A GB0716591D0 (en) 2007-08-24 2007-08-24 Composition
AU2008291930A AU2008291930B2 (en) 2007-08-24 2008-08-22 Compositions for the treatment of neoplastic diseases
BRPI0816144-5A BRPI0816144B1 (pt) 2007-08-24 2008-08-22 Composição farmacêutica sólida para administração oral, uso da mesma e método para a preparação da dita composição
ES08788414.4T ES2535401T3 (es) 2007-08-24 2008-08-22 Composiciones para el tratamiento de enfermedades neoplásicas
EP08788414.4A EP2190413B1 (en) 2007-08-24 2008-08-22 Compositions for the treatment of neoplastic diseases
KR1020107004111A KR101544498B1 (ko) 2007-08-24 2008-08-22 종양성 질환의 치료를 위한 조성물
RU2010110658/15A RU2488384C2 (ru) 2007-08-24 2008-08-22 Композиции для лечения неопластических заболеваний
PCT/GB2008/002854 WO2009027644A2 (en) 2007-08-24 2008-08-22 Composition
MX2010002179A MX2010002179A (es) 2007-08-24 2008-08-22 Composicion para el tratamiento de enfermedades neoplasicas.
CN2008801042752A CN101854919B (zh) 2007-08-24 2008-08-22 用于治疗肿瘤疾病的组合物
HK10110968.5A HK1144390B (en) 2007-08-24 2008-08-22 Compositions for the treatment of neoplastic diseases
CA2696622A CA2696622C (en) 2007-08-24 2008-08-22 Compositions for the treatment of neoplastic diseases
JP2010521478A JP5404625B2 (ja) 2007-08-24 2008-08-22 組成物
ARP090103252A AR073123A1 (es) 2007-08-24 2009-08-24 Composicion farmaceutica que comprende un taxano sustancialmente amorfo para utilizarse en el tratamiento de la enfermedad neoplasica
CL2009001766A CL2009001766A1 (es) 2007-08-24 2009-08-24 Composicion farmaceutica solida para administracion oral que comprende: un taxano sustancialmente amorfo definido, un portador hidrofilico definido y un tensoactivo definido; metodo para preparar la composicion; y su uso para tratar una enfermedad neoplasica.
US13/060,037 US20110207804A1 (en) 2007-08-24 2009-08-24 Compositions for the treatment of neoplastic diseases
ZA2010/01304A ZA201001304B (en) 2007-08-24 2010-02-23 Compositions for the treatment of neoplastic diseases
IL204115A IL204115B (en) 2007-08-24 2010-02-23 Compositions comprising a taxane and a surfactant and uses thereof in the treatment of neoplastic disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0716591A GB0716591D0 (en) 2007-08-24 2007-08-24 Composition

Publications (1)

Publication Number Publication Date
GB0716591D0 true GB0716591D0 (en) 2007-10-03

Family

ID=38599259

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0716591A Ceased GB0716591D0 (en) 2007-08-24 2007-08-24 Composition

Country Status (5)

Country Link
JP (1) JP5404625B2 (enExample)
CN (1) CN101854919B (enExample)
ES (1) ES2535401T3 (enExample)
GB (1) GB0716591D0 (enExample)
RU (1) RU2488384C2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR086913A1 (es) * 2011-06-14 2014-01-29 Novartis Ag 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]-amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-fenil]-benzamida amorfa, forma de dosificacion que la contiene y metodo para prepararlas
WO2015152433A1 (en) 2014-03-31 2015-10-08 Hanmi Pharm. Co., Ltd. Amorphous solid dispersion comprising paclitaxel, tablet comprising the same, and method for preparing the same
CN105106420A (zh) * 2015-07-30 2015-12-02 马衍福 一种抗肿瘤疾病中药制剂
JP2020514359A (ja) 2017-03-15 2020-05-21 ディーエフビー ソリア リミテッド ライアビリティ カンパニー タキサンのナノ粒子を用いる皮膚悪性腫瘍処置のための局所療法
CN111465389B (zh) 2017-09-07 2022-06-21 深圳信立泰药业股份有限公司 多西他赛共缀物的药物组合物及制备方法
CN113473982A (zh) * 2018-12-21 2021-10-01 莫德拉药物股份有限责任公司 使用多西他赛和cyp3a抑制剂组合治疗实体瘤
PE20220250A1 (es) * 2018-12-21 2022-02-16 Modra Pharmaceuticals B V Uso de docetaxel en el tratamiento de cancer mediante control de niveles maximos en plasma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1048956B (zh) * 1999-05-27 2006-07-28 阿库斯菲尔公司 多孔药物基质及其制造方法
EP1539111A1 (en) * 2002-08-05 2005-06-15 DSM IP Assets B.V. Oral dosage forms of water insoluble drugs and methods of making the same
KR100508518B1 (ko) * 2002-11-13 2005-08-17 한미약품 주식회사 초임계유체 공정을 이용한 파클리탁셀 고체분산체의 제조방법 및 이 방법으로 제조된 파클리탁셀 고체분산체
WO2004050068A1 (en) * 2002-11-29 2004-06-17 Janssen Pharmaceutica N.V. Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base

Also Published As

Publication number Publication date
JP5404625B2 (ja) 2014-02-05
BRPI0816144A2 (pt) 2015-02-18
JP2010536837A (ja) 2010-12-02
RU2010110658A (ru) 2011-09-27
CN101854919A (zh) 2010-10-06
RU2488384C2 (ru) 2013-07-27
ES2535401T3 (es) 2015-05-11
CN101854919B (zh) 2012-02-15

Similar Documents

Publication Publication Date Title
GB0718777D0 (en) Composition
GB0700534D0 (en) Composition
GB0717182D0 (en) Composition
PL2118255T5 (pl) Środek czyszczący
ZA200907382B (en) Composition
ZA200908273B (en) Composition
GB0710888D0 (en) Composition
SI2154121T1 (sl) Biognojilni sestavek
GB0716591D0 (en) Composition
GB0714569D0 (en) Composition
GB0705885D0 (en) Composition
GB0703719D0 (en) Composition
GB0706343D0 (en) Composition
GB0702446D0 (en) Composition
GB0707972D0 (en) Composition
GB0706739D0 (en) Composition
GB0704651D0 (en) Composition
ZA200906258B (en) Composition
GB0723825D0 (en) Composition
GB0721430D0 (en) Composition
GB0713976D0 (en) Composition
GB0710559D0 (en) Composition
GB0703087D0 (en) Composition
GB0714237D0 (en) composition
GB0717386D0 (en) Composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)